Processa Pharma director awarded 62,221 RSUs
Neal James R reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Neal James R reported acquisition or exercise transactions in this Form 4 filing.
Processa Pharmaceuticals, Inc. director Neal James R received a grant of 62,221 Restricted Stock Units (RSUs) on July 26, 2026, each representing one share of common stock. The RSUs vested upon grant but will be distributed only upon termination, six months after grant, a change of control, or death. Following this award, he holds 67,470 RSUs, stock options for 12,000 shares at $4.96 vesting over three years, and 1,021 common shares, all on a direct-ownership basis. Reported amounts reflect a 1-for-25 reverse stock split effective December 17, 2025.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 62,221 shares
Grant/Award
3 txns
Insider
Neal James R
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units F1, F3 | 62,221 | $0.00 | $0.00 |
| holding | Stock Options (Right to Buy) F2, F3 | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Units — 67,470 contracts (Direct);
Stock Options (Right to Buy) — 12,000 contracts (Direct);
Common Stock — 1,021 shares (Direct)
Footnotes (3)
- F1. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death.
- F2. Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years.
- F3. Reflects the 1-for-25 reverse stock split effected by the Issuer on December 17, 2025.
Key Figures
RSUs granted: 62,221 units
RSUs outstanding after grant: 67,470 units
Option exercise price: $4.96 per share
+3 more
6 metrics
RSUs granted
62,221 units
Restricted Stock Units granted to director on July 26, 2026
RSUs outstanding after grant
67,470 units
Total Restricted Stock Units held directly after the reported grant
Option exercise price
$4.96 per share
Exercise price for director stock options over 12,000 underlying shares
Underlying option shares
12,000 shares
Common shares underlying stock options held directly after the transaction
Common shares held
1,021 shares
Directly owned Processa Pharmaceuticals common stock position
Reverse stock split ratio
1-for-25
Reverse split of common stock effective December 17, 2025
Key Terms
Restricted Stock Units, Stock options, reverse stock split, change of control
4 terms
Restricted Stock Units financial
"Each Restricted Stock Unit represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock options financial
"Stock options vest one-third on the first anniversary date of the grant"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
reverse stock split financial
"Reflects the 1-for-25 reverse stock split effected by the Issuer"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.
change of control financial
"distributed until the earlier of termination, six months, change of control, or death"
A change of control occurs when the ownership or management of a company shifts significantly, such as through a sale, merger, or acquisition, resulting in new leadership or ownership structure. This change can impact the company's direction and decision-making, which is important for investors because it may affect the company's stability, strategy, and future prospects.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider equity award did Processa Pharmaceuticals (PCSA) report for director Neal James R?
Neal James R received a grant of 62,221 Restricted Stock Units (RSUs) on July 26, 2026. Each RSU represents a right to one common share, vesting immediately but distributed later upon termination, six months after grant, change of control, or death.
How many RSUs does Processa Pharmaceuticals (PCSA) director Neal James R now hold?
After the award, Neal James R holds 67,470 Restricted Stock Units directly. These RSUs have vested but will be settled in common stock only upon specified future events, including termination, six months after grant, change of control, or death.
What are the key terms of Neal James R’s stock options reported by PCSA?
He holds stock options over 12,000 shares of common stock with an exercise price of $4.96 per share. The options vest one-third on the first anniversary of the grant, with the remaining two-thirds vesting ratably over the following two years.
Were the PCSA insider equity awards to Neal James R made under a Rule 10b5-1 trading plan?
The filing’s Rule 10b5-1 checkbox is not marked as relying on a 10b5-1 plan. There is no footnote indicating that the RSU grant or option holdings were executed under a pre-arranged Rule 10b5-1 trading arrangement.
How did Processa Pharmaceuticals’ 1-for-25 reverse stock split affect Neal James R’s reported holdings?
All reported holdings reflect a 1-for-25 reverse stock split effective December 17, 2025. A footnote clarifies that the RSU and option share amounts shown have already been adjusted to account for this reverse split.
AI-generated analysis. How Rhea-AI works. Not financial advice.
